Simulations Plus Inc.


SLP

Price

49.67


Change

-0.31


High

NA


Low

NA


Avg Volume

73,833


PE Ratio

95.76


52 Week High

52.2


52 Week Low

32.5



Profile

Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a leading provider of clinical trial data analysis and consulting services. The company has produced specific proprietary software products, such as:


Top Streaming News


Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.

Data provided by IEX Cloud

About

Copyright © 2020 Finaza.IO. All Rights Reserved.